טופיתרים 25 Izraēla - ivrits - Ministry of Health

טופיתרים 25

trima israel pharmaceutical products maabarot ltd - topiramate - טבליה - topiramate 25 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topitim is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topitrim is indicated in adults for the prevention of migraines. the use of topitrim in the acute treatment of migraine has not been studied.

טופיתרים 50 Izraēla - ivrits - Ministry of Health

טופיתרים 50

trima israel pharmaceutical products maabarot ltd - topiramate - טבליה - topiramate 50 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topitim is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topitrim is indicated in adults for the prevention of migraines. the use of topitrim in the acute treatment of migraine has not been studied.

טופיתרים 100 Izraēla - ivrits - Ministry of Health

טופיתרים 100

trima israel pharmaceutical products maabarot ltd - topiramate - טבליה - topiramate 100 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topitim is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topitrim is indicated in adults for the prevention of migraines. the use of topitrim in the acute treatment of migraine has not been studied.

טופיתרים 200 Izraēla - ivrits - Ministry of Health

טופיתרים 200

trima israel pharmaceutical products maabarot ltd - topiramate - טבליה - topiramate 200 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topitim is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topitrim is indicated in adults for the prevention of migraines. the use of topitrim in the acute treatment of migraine has not been studied.

גאבאפנטין טבע  300 מג Izraēla - ivrits - Ministry of Health

גאבאפנטין טבע 300 מג

teva pharmaceutical industries ltd, israel - gabapentin - קפסולות - gabapentin 300 mg - gabapentin - gabapentin - - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy. - for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy (neuralgia).

גאבאפנטין טבע  400 מג Izraēla - ivrits - Ministry of Health

גאבאפנטין טבע 400 מג

teva pharmaceutical industries ltd, israel - gabapentin - קפסולות - gabapentin 400 mg - gabapentin - gabapentin - - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy. - for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy (neuralgia).

קבותרים 0.5 Izraēla - ivrits - Ministry of Health

קבותרים 0.5

trima israel pharmaceutical products maabarot ltd - cabergoline - טבליה - cabergoline 0.5 mg - dopa and dopa derivatives - treatment of hyperprolactinemic disorders.cabotrim is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. cabotrim is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .

אטנט 10 מג Izraēla - ivrits - Ministry of Health

אטנט 10 מג

teva pharmaceutical industries ltd, israel - amphetamine aspartate monohydrate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate - טבליה - amphetamine sulfate 2.500 mg; dextroamphetamine sulfate 2.500 mg; amphetamine aspartate monohydrate 2.500 mg; dextroamphetamine saccharate 2.500 mg - amfetamine

אטנט 20 מג Izraēla - ivrits - Ministry of Health

אטנט 20 מג

teva pharmaceutical industries ltd, israel - amphetamine aspartate monohydrate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate - טבליה - amphetamine sulfate 5.000 mg; dextroamphetamine sulfate 5.000 mg; amphetamine aspartate monohydrate 5.000 mg; dextroamphetamine saccharate 5.000 mg - dexamfetamine

אטנט 30 מג Izraēla - ivrits - Ministry of Health

אטנט 30 מג

teva pharmaceutical industries ltd, israel - amphetamine aspartate monohydrate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate - טבליה - amphetamine sulfate 7.500 mg; dextroamphetamine sulfate 7.500 mg; amphetamine aspartate monohydrate 7.500 mg; dextroamphetamine saccharate 7.500 mg - dexamfetamine